Mesenchymal-to-epithelial transition (MET) is an important step in cell reprogramming from fibroblasts (a cell type frequently used for this purpose) to various epithelial cell types. However, the mechanism underlying MET induction in fibroblasts remains to be understood. The present study aimed to identify the transcription factors (TFs) that efficiently induce MET in dermal fibroblasts. OVOL2 was identified as a potent inducer of key epithelial genes, and OVOL2 cooperatively enhanced MET induced by HNF1A, TP63, and KLF4, which are known reprogramming TFs to epithelial lineages. In TP63/KLF4-induced keratinocyte-like cell-state reprogramming, OVOL2 greatly facilitated the activation of epithelial and keratinocyte-specific genes. This was accompanied by enhanced changes in chromatin accessibility across the genome. Mechanistically, motif enrichment analysis revealed that the target loci of KLF4 and TP63 become accessible upon induction of TFs, whereas the OVOL2 target loci become inaccessible. This indicates that KLF4 and TP63 positively regulate keratinocyte-associated genes whereas OVOL2 suppresses fibroblast-associated genes. The exogenous expression of OVOL2 therefore disrupts fibroblast lineage identity and facilitates fibroblast cell reprogramming into epithelial lineages cooperatively with tissue-specific reprogramming factors. Identification of OVOL2 as a MET inducer and an epithelial reprogramming enhancer in fibroblasts provides new insights into cellular reprogramming improvement for future applications.
INTRODUCTION
Fibroblasts are mesenchymal cells most frequently used for cell reprogramming. Several studies have established the importance of mesenchymal-to-epithelial transition (MET) to reprogram fibroblasts into various epithelial cell types. The initial stages of induced pluripotent stem cell (iPSC) reprogramming from fibroblasts require MET, and its efficiency is significantly suppressed by MET inhibition [1] [2] [3] . MET is also involved in fibroblasts' direct cell reprogramming into an epithelial hepatocytelike state 4 . In fact, the mesenchymal identity of fibroblasts is maintained/protected by multiple mesenchymal (M)-epithelial (E) barriers, including DNA methylation 5 , barrier kinases 6 , and microRNAs 7 . This suggests that activating the intrinsic MET program may enhance the efficiency of cellular reprogramming of fibroblasts into epithelial cell lineages. However, MET induction in fibroblasts has not been fully explored.
Epithelial-to-mesenchymal transition (EMT), an opposite process of MET, is involved in developmental dynamic tissue morphogenesis, as well as in fibrosis, invasion, metastasis, stemness, and chemo-resistance of tumor cells under pathological conditions 8 . Therefore, the underlying mechanism of EMT has been extensively studied over decades, and several transcription factors such as SNAIL/SLUG, ZEB, and TWIST families have been identified as EMT-inducing transcription factors (EMT-TFs) 9 . On the other hand, MET has recently drawn attention as an attractive target for cancer therapy 10 and several TFs have been found to exhibit MET-inducing activity (MET-TFs). In various cancer cells, GRHL2 is associated with epithelial phenotype 11 and activates epithelial enhancer subsets during the early differentiation of pluripotent cells 12 . The OVOL family induces MET in several cancer cell types 13 and protects the epithelial identity of normal epithelial cells 14, 15 , whereas the ELF family is reported to inhibit EMT in ovarian cancer 16 and mammary epithelial cells 17 . GATA3 initiates MET in breast cancer cells as a pioneer TF 18 , whereas FOXA1 and FOXA3 maintain the expression of key epithelial genes in colorectal cancer cells 19 and KLF4 exhibits MET-inducing activity during iPSC reprogramming 20 . However, MET-TF(s) that can efficiently induce MET in fibroblasts remain to be identified.
The present study aimed to identify TFs that can activate MET in dermal fibroblasts. We identified OVOL2 as a potent MET-TF enhancer, which can cooperatively induce MET with known reprogramming TFs, HNF1A, TP63, and KLF4. We also demonstrated that OVOL2 facilitates KLF4/TP63-induced keratinocyte-like cell state in fibroblasts. The Assay for Transposase-Accessibility of Chromatin (ATAC)-seq analysis disclosed a mechanism where KLF4/TP63 and OVOL2 play different roles in the regulation of chromatin accessibility in their target loci.
RESULTS

Selection of MET-TF candidates in fibroblasts
To identify the TFs promoting MET in fibroblasts, we first selected candidate MET-TFs among 1995 TF genes annotated by functional annotation of mammalian genome 5 (FANTOM5) 21 , based on a positive or negative expression correlation with E or M markers, respectively. CDH1 and VIM were used as representative E and M marker genes, respectively, since the expression of these genes showed the strongest anti-correlation among typical E and M markers in two public gene expression databases: the Cancer Cell Line Encyclopedia (CCLE, https://portals.broadinstitute.org/ccle/) and the FANTOM5 ( Figure S1 ). We calculated and plotted the Pearson correlation coefficient r, between the expression of TF genes and the expression of CDH1 or VIM, across 1038 CCLE microarrays for cancer cell lines representing various degrees of E and M states ( Figure 1A ). As expected, known MET-TF genes, the OVOL 13 and GRHL 11 families, exhibited a strongly positive correlation with CDH1 and a negative correlation with VIM, whereas known EMT-TF genes, the SNAI, TWIST, and ZEB families, exhibited opposite correlations, thus confirming the validity of this approach. Ten candidate MET-TFs were selected from this plot (i.e., ANKRD22, EHF, ELF3, FOXA1, GRHL1/2/3, IRF6, OVOL2, and ZNF165).
In addition, GATA3 18 , FOXA3 19 , HNF1A 22 , KLF4 20 , and TP63 23 were selected on the basis of their previously reported involvement in MET activation or EMT suppression. A correlation between these candidate factors and the E state was also observed in 1829 FANTOM5 data for normal primary cell types ( Figure S2 ), where YBX2 was selected on the basis of its strong association with the E state. This resulted in a list of 16 candidate MET-TFs (Table 1) .
Identification of OVOL2 as a potent MET inducer in dermal fibroblasts
The 16 selected TFs were then tested for their potential to induce MET in human neonatal dermal fibroblasts (HNDFs) by ectopic expression. When they were simultaneously introduced by pooled lentiviral vectors at a MOI of 20 (1.25 MOI for each TF), a subset of HNDFs started to form colonies with epithelial morphology ( Figure 1B) . The E marker proteins E-cadherin and cytokeratins were detected along with the morphological changes, whereas no changes were observed in the M marker vimentin ( Figure 1C) , likely because the epithelial conversion occurred in a small cell population, with most of the cells remaining in the mesenchymal state. These results suggest that the 16 candidate TFs contain factor(s) that can promote MET in fibroblasts.
We then looked for essential MET-TFs among the 16 candidates, by performing an "all-minusone" screening based on Yamanaka's approach, which was used when the minimum set of iPSC reprogramming factors was discovered by his group 24 (Figure 2A ). This screening revealed that, among the 16 candidates, OVOL2 is the only indispensable factor for the induction of the E marker gene CDH1.
However, OVOL2 alone was not sufficient to activate CDH1 expression to the level achieved by all 16 factors ( Figure 2B ). Therefore, we hypothesized that other factors might activate CDH1 expression cooperatively with OVOL2. To test this hypothesis, we performed an "OVOL2-plus-one" screening and found that HNF1A, TP63, and KLF4 exhibited the highest enhancement of OVOL2-induced CDH1 expression ( Figure 2C ), which was confirmed to be statistically significant ( Figure 2B ).
OVOL2 enhances reprogramming-mediated MET
The cooperative factors of OVOL2-induced CDH1 expression, HNF1A, TP63, and KLF4, are involved in several processes of fibroblast reprogramming into epithelial lineages [25] [26] [27] . Overexpression of TP63 together with KLF4 was reported to induce a keratinocyte-like state in human fibroblasts 20 . In addition, previous studies used multiple TF combinations including HNF1A, HNF4A, and FOXA factors to reprogram human or mouse fibroblasts into hepatocyte-like state 25, 27 . Therefore, we hypothesized that reprogramming-mediated MET in keratinocyte-or hepatocyte-like states may be enhanced by OVOL2.
To test this hypothesis, we investigated keratinocyte-and hepatocyte-like reprogramming using combinations of TP63/KLF4 (TK) and HNF1A/HNF4A/FOXA3 (HF), respectively, with or without OVOL2.
A tetracycline-inducible lentiviral vector was generated using dual selection to control the expression of OVOL2 and TK or HF (See Methods section for details). To determine the cooperative enhancement of MET by the factor combinations, the TFs induction levels were set such that HF, TK, or OVOL2 could not, by themselves, show detectable morphological changes within 4-5 days after doxycycline (DOX) induction (bottom left or upper right in Figure 3A and B). However, under the same conditions, the combination of OVOL2 with either TK or HF (TK + OVOL2 or HF + OVOL2) dramatically facilitated epithelial-like morphological changes and became less proliferative (bottom right in Figure 3A and B).
Further, both TK + OVOL2 and HF + OVOL2 combinations dramatically suppressed the directional migration phenotype, which is an important feature of MET 28 , as compared with the respective controls including negative control vectors (Control), OVOL2 alone (OVOL2), TK alone (TK), and HF alone (HF) ( Figure 3C ). These data implicate that, in fibroblasts, functional MET is facilitated by the combination of TK + OVOL2 or HF + OVOL2.
Cooperative induction of a keratinocyte-like state by the combination of OVOL2 and TP63/KLF4
Next, we examined whether OVOL2 facilitates fibroblast reprogramming into specific epithelial lineages.
Since several previous studies reported the conserved role of the OVOL family factors during ectodermal tissue development 29, 30 , we investigated the involvement of OVOL2 in the reprogramming of HNDFs into the keratinocyte-like state. The results showed that TK + OVOL2-transduced HNDFs showed a dramatically increased expression of the keratinocyte-specific (K) marker genes KRT14 and TP63 ( Figure 4A ). Consistent with the changes in morphology/physiology (Figure 3) , the E marker CDH1 was dramatically induced by the combination of TK + OVOL2 ( Figure 4A) . Importantly, the expression of the M marker VIM was significantly reduced by TK + OVOL2, thus confirming M-state suppression concurrently to E-state activation ( Figure 4A ). Furthermore, transduction of TK + OVOL2
in HNDFs resulted in a dramatic increase of a KRT14 protein-expressing cell population at a 43% rate, whereas with TK, only 5.8% of cells became KRT14 positive ( Figure 4B ). This suggests that the reprogramming efficiency was increased at the population level. Taken together, these results support that the combination of TK + OVOL2 cooperatively facilitates HNDF reprogramming both at cellular and gene expression levels toward the keratinocyte-like state through activation of the keratinocyte-specific transcriptional regulatory network with MET enhancement.
The combination of TP63/KLF4 and OVOL2 enhanced transcription and chromatin accessibility changes toward the keratinocyte-like state Chromatin state directly reflects the lineage identity of a given cell, providing clues to understand the regulatory mechanisms of cell-state transitions 31 . Therefore, we evaluated changes in chromatin accessibility following induction of TF combinations in HNDFs, using ATAC-seq 32 Interestingly, roadmap-defined CDH1 enhancers 33 showed an open chromatin state only under OVOL2 expression, whereas VIM enhancers showed a tendency toward the closed chromatin state by the combination of TK + OVOL2 ( Figure 5A , marked in blue). This suggests that those loci are involved in the cell reprogramming mechanism. We then compared chromatin state changes with transcriptomic changes assessed by CAGE 34 . At a genome-wide scale, TK + OVOL2-transduced HNDFs showed greater changes toward keratinocyte-like state than either OVOL2 or TK alone, both in CAGE and in ATAC-seq data ( Figure S3 ). Next, we created a list of E, K, M, fibroblast (F)-specific gene sets based on previous literature (Table S1) [35] [36] [37] [38] and investigated how these gene categories would behave transcriptionally and how their corresponding chromatin accessibility would behave epigenetically during reprogramming ( Figure 5B ). The combination of TK + OVOL2 markedly enhanced both the transcriptional activity and the chromatin accessibility of E and K genes. In contrast, both OVOL2 and TK alone failed to induce expression and chromatin accessibility in E and K genes, apart from a mild activation of E gene expression by OVOL2 alone. On the other hand, the expression of M genes was inhibited by either OVOL2 or TK alone, which was further enhanced by the combination of TK + OVOL2, whereas chromatin accessibility changes were observed only for TK + OVOL2. Transcriptional inhibition of F genes was observed only in the TK + OVOL2-introduced HNDFs. However, chromatin accessibility did not show significant changes. These results indicate that TK + OVOL2 substantially enhances epigenetic changes of HNDFs toward keratinocyte-like state at representative genomic loci, and most of transcriptional changes are accompanied by changes in the chromatin state.
Distinct regulation of chromatin accessibility by OVOL2 and TP63/KLF4
Chromatin accessibility evaluation is a powerful approach to dissect the activity of regulatory elements through TF-binding motif analysis 39 . To understand the transcriptional regulatory networks that define fibroblast and keratinocyte lineages, we investigated the differences in enriched TF-binding motifs at open chromatin loci between primary fibroblasts (i.e., control HNDF) and primary keratinocytes using the analytical program chromVAR 40 . Among the 808 curated TF motifs used in the analysis, 34 were significantly more accessible in fibroblasts whereas 72 were significantly more accessible in keratinocytes (q < 0.01 and enrichment_score > 5) ( Figure 6A , Table S2 ). Among them, 9 out of 34 and 18 out of 72 showed a significantly different expression in the CAGE data (q value <0.01 and |log fold change| > 1; Figure 6B ). This unbiased analysis revealed that TP63 and KLF4 motifs were significantly more accessible in keratinocytes, indicating the importance of these factors to specify the keratinocyte lineage ( Figure 6A ). In contrast, OVOL1/2 motifs were significantly more accessible in primary fibroblasts ( Figure 6A ). When directly compared with the CAGE expression data ( Figure 6C Table 1 showed significant differences between the two cell lineages regarding their motif accessibilities (Table S2) .
Next, we investigated how these factors change their motif accessibilities during reprogramming. In a t-SNE plot generated by the motif enrichment scores, TK + OVOL2-treated cells became closer to primary keratinocytes than control, OVOL2, or TK-treated cells ( Figure 7A ). We then compared the motif enrichment of individual factors in open chromatin peaks for each condition ( Figure   7B ). The OVOL2 motif became inaccessible in TK + OVOL2-treated HNDFs at a level similar to keratinocytes, and its expression level increased in TK + OVOL2-treated HNDFs. TP63 expression and motif enrichment was dramatically elevated in keratinocytes and elevated to a lesser extent in TK + OVOL2-treated HNDFs. Overall, KLF4 showed a consistent increase in motif enrichment and gene expression during reprogramming toward keratinocyte-like state, except for an increase in the transcript observed in TK alone, which could have been caused by contamination of exogenously introduced sequences. Overall, a positive correlation was observed between the expression and motif enrichment of TP63 and KLF4. In addition to reprogramming TFs, ZEB1 and ID3 showed similar reciprocity between gene expression and motif activity, as these factors were highly expressed in control HNDFs, but motifs were enriched in activated peaks of TK-OVOL2-treated HNDFs and keratinocytes ( Figure S4 ). These results indicate that OVOL2 and TK regulates the MET process through distinct chromatin regulation mechanisms (negative vs positive), which may have caused enhanced transition of fibroblasts into epithelial lineages.
DISCUSSION
Identification of OVOL2 as a potent MET inducer in dermal fibroblasts
The present study aimed to identify potent MET-TFs in fibroblasts. Our candidate list contained factors previously reported as regulators of MET, the GRHL family factors 11,12 ELF3 16 , GATA3 18 , FOXA1/3 19 , KLF4 20 , and OVOL2 [13] [14] [15] . However, among them OVOL2 was the only essential factor to induce E genes in our screening (Figure 2 ). OVOL2 and its homologue OVOL1 (not included in this study due to a technical reason) were previously reported to induce MET in various types of cancer cells 13 and to protect the epithelial identity of normal epithelial cells 14, 15 . The current study extends these findings to fibroblasts, a non-epithelial cell type with an established M state. The fact that other candidate TFs with potential MET-inducing activities in other cell types did not show any potent effect in fibroblasts may implicate that epithelial programs are strongly suppressed in fibroblasts where OVOL2 can only break this barrier. Consistently, OVOL2 was the only factor showing differential motif accessibility in ATACseq analysis, among the candidate factors (Table S2) .
Mechanistically, the ATAC-seq results indicated that OVOL2 induces a closed chromatin state at its target loci, which is consistent with a previous report demonstrating that OVOL2 acts primarily as a transcription repressor in epithelial cells 15 . This indicates that OVOL2 activates E (and K) genes indirectly. How does OVOL2 activate these genes? ATAC-seq analysis revealed that TFs' motifcontaining regions, including ZEB1 and ID3, are significantly accessible in keratinocytes and become accessible in fibroblasts upon introduction of TK + OVOL2. ZEB1 is an EMT-TF that plays an essential role for the maintenance of the M phenotype. In fact, previous studies have demonstrated that ZEB1 is a repressor of many E genes including CDH1 41 and constitutes an important target of OVOL2 15 . On the other hand, ID3 exhibits a broad biological effect and its involvement in MET has not been clearly demonstrated 42 . Therefore, a potential mechanism underlying OVOL2-mediated E gene activation resides in inducing suppression of the ZEB1 repressor (= de-repression of E genes), which may comprise a prerequisite of MET induction in fibroblasts.
Reprogramming-mediated MET was enhanced by OVOL2
Our screening also identified OVOL2 as a cooperative MET inducer, when introduced together with the epithelial reprogramming factors HNF1A, TP63, and KLF4. Our results indicate that TP63/KLF4 directly activate their targets, including E and K factors at a chromatin level, as their expression and motif accessibility were positively correlated (Figures 6 and 7) . Therefore, TP63/KLF4-mediated MET must occur via mechanisms different from OVOL2. These factors therefore use independent pathways to activate E genes, resulting in a cooperative MET induction in fibroblasts.
The combined effect of OVOL2 and TP63 may be relevant in physiological settings, since their expression patterns are important for the development and maintenance of ectodermal tissues. For example, OVOL2 and TP63 are co-expressed in the basal layer of the interfollicular epidermis 14 , but mutually exclusively expressed in mammary epithelium, since OVOL2 is preferentially expressed in luminal layers 15 , whereas TP63 is specifically expressed in basal myoepithelial cells 43 . This might be related with the fact that mammary basal cells (i.e., myoepithelial cells) exhibit less epithelial phenotypes than basal keratinocytes. Further in vivo studies are needed to investigate how these factors interact to regulate epithelial fate.
OVOL2 facilitates cell-state changes of fibroblasts towards specific epithelial lineages
Our results also indicate that OVOL2-mediated MET facilitates cell-state changes toward specific epithelial lineages such as keratinocytes. In this context, our previous reports demonstrated that suppression of the fibroblast-specific TF network facilitates the direct reprogramming of fibroblasts into specific lineages such as adipocytes or monocytes 38, 44 . This suggests that, in direct cell reprogramming, suppression of original cell-state is critical to activate the TF network of the target state. Along this line, it has been reported that miR200 families also enhance iPSC induction through EMT-TFs suppression in fibroblasts 3 . Similarly, our results indicate that exogenous OVOL2 expression suppresses the original M state in fibroblasts, promoting the transition toward the E state ( Figure 7C ). Therefore, suppression of the original M state may be a key event to enhance the epithelial reprogramming of fibroblasts.
Conclusions
The present study revealed the potent MET-inducing role of OVOL2 in fibroblasts and showed that TP63/KLF4-mediated MET was further enhanced by OVOL2. In addition, we demonstrated that 
METHODS
Cell culture and transdifferentiation
HNDF (Lonza, Switzerland) were grown in αMEM (Thermo Fisher, USA) supplemented with 10% fetal bovine serum. Primary keratinocytes (Lonza) were grown in KGM-Gold™ Keratinocyte Growth Medium (Lonza). For TF-mediated reprogramming into keratinocyte-like state, culture media were switched from αMEM to KGM-Gold™ after introduction of the indicated TFs. For TF-mediated reprogramming into hepatocyte-like state, culture media were switched from αMEM to HGM™ Hepatocyte Growth Medium (Lonza) and cells were plated onto collagen I-coated plates (Thermo Fisher) at the first passage after TF induction.
Lentiviral expression systems
Candidate MET-TFs with cDNAs available in our cDNA collection were selected ( Table 1 ). The initial screening was performed by cloning cDNAs into CSII-EF-RfA-IRES2-Puro lentiviral construct 45 .
Inducible expression of TP63, KLF4, HNF1A, HNF4A, and FOXA3 was achieved using a lentiviral expression construct with puromycin resistance (pCW57.1, a gift from David Root, Addgene plasmid # 41393). Inducible expression of OVOL2 was achieved using a construct with hygromycin resistance (pSLIK-Hygro, a gift from Iain Fraser, Addgene plasmid # 25737). Optimal transduction efficiency with low multiplicity of infection (MOI) was achieved by dual selection using hygromycin-and puromycinresistant constructs. Lentiviruses were prepared in a mixture of the following packaging constructs:
pCMV-VSV-G-RSV-Rev and pCAG-HIVgp (provided by RIKEN BRC, Japan). The nuclear red fluorescent protein (RFP)-expressing lentiviral construct (LV-RFP) was a gift from Elaine Fuchs (Addgene plasmid # 26001). To infect lentiviruses, HNDFs were seeded in a 6-well plate at a density of 1 × 10 6 cells/well, followed by transduction, performed on the second day by adding 8 µg/mL polybrene and 10 MOI of lentivirus into each well. The antibiotics selection was started 2 days after transduction.
Immunocytochemistry
Cells grown in 8-well-chambered slide (Thermo Fisher) were fixed in 4% paraformaldehyde, then permeabilized with 0.2% Triton X-100. After washing and blocking, cells were stained with rabbit polyclonal anti-β-catenin antibody (1:1000, H-102, Santa Cruz, USA) and labeled with the secondary antibody conjugated with Alexa-Fluor-488. Counterstaining was performed with DAPI.
Western blotting
Total protein was extracted from cells by lysing with radioimmunoprecipitation assay buffer (Takara, Japan). Ten micrograms of protein were run on 4-20% gradient polyacrylamide gels (Thermo Fisher) and transferred to nitrocellulose membranes (Merck, Germany). The membranes were then blocked with 5% nonfat milk in Tris-buffered saline with Tween20 (10 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween20) and probed with the following antibodies: anti-E-cadherin (BD Biosciences, USA, 1:1000), anti-pan-cytokeratin (Wako, Japan, 1:1000), anti-Vimentin (Cell Signaling Technologies, USA, 1:1000), and anti-β-actin (Sigma-Aldrich, USA, 1:5000).
Cell physiology assays
Cell motility was quantified by image-based analysis using a live-cell imaging device, the IncuCyte (Essen Bioscience, USA). Cellular movement was tracked by nuclear RFP signals from HNDFs that had been infected with LV-RFP. Cell images were taken every 15 min, and each fluorescent spot was tracked using the Fiji Trackmate. Each spot's coordinates at each time point were used to calculate the mean squared displacement (MSD) using the following formula: MSD = ( 〖 (x(t) − x(0)) 〗^2+ 〖(y(t) − y(0))〗^2)/t. Within each track, the values for all time points were filtered and the maximum MSD was kept and divided by the time duration of the track to adjust for time dependency. The timeadjusted MSD values for all tracks were averaged to obtain the representative MSD value for each cell group.
Quantitative RT-PCR (RT-qPCR)
Total RNA was isolated using a QIAGEN miRNeasy mini kit (QIAGEN, Germany), and first-stranded cDNA was prepared using the Prime Script RT kit (Takara) according to the manufacturer's instructions.
Real-time PCR was performed using a StepOnePlus™ real-time PCR system (Thermo Fisher), with SYBR Premix Ex Taq™ II (Takara). Comparative analysis was performed for the genes of interest, which were normalized by the housekeeping genes GAPDH and ACTB. The primer sequences used in this study are presented in Table S3 .
Cap analysis of gene expression (CAGE)
CAGE libraries were prepared as previously described 46 . Briefly, 3 μg of total RNA from each sample were subjected to reverse transcription, using SuperScript III Reverse Transcriptase (Thermo Fisher) with random primers. The 5-end cap structure was biotinylated by sequential oxidation with NaIO4 and biotinylation with biotin hydrazide (Vector Laboratories, USA). After RNase I treatment (Promega, USA), the biotinylated cap structure was captured with streptavidin-coated magnetic beads (Thermo Fisher).
After ligation of 5' and 3' adaptors, second-strand cDNA was synthesized with DeepVent (exo−) DNA polymerase (New England BioLabs, USA). The double-stranded cDNA was treated with exonuclease I (New England BioLabs) and purified. The resulting CAGE libraries were sequenced using single-end reads of 50 bp on the Illumina HiSeq 2500 (Illumina, USA). CAGE data for the primary keratinocytes were obtained from the FANTOM5 data resource (http://fantom.gsc.riken.jp/5/sstar/Main_Page). The extracted CAGE tags were then mapped to the human genome (hg38). After filtering low-quality reads, mapped CAGE tags were counted regarding FANTOM5-CAT TSSs 47 , providing a unit of CAGE tag start site. The tags per million (tpm) were calculated for each TSS peak and computed as gene expression levels for multiple TSS peaks associated with a single gene.
ATAC-seq
ATAC-seq was performed as previously described, with some modifications 32 . Samples stored in the Cell banker (Takara) at −80 °C were used in this study. After thawing, the cell number and viability were quantified with Countes (Thermo Fisher), and the nuclei were extracted from approximately 25,000 live cells with CSK buffer (10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.1% Triton X-100) on ice for 5 min. Transposase reaction was then performed, followed by 9 to 12 total cycles of PCR amplification. Amplified DNA fragments were then purified with the QIAGEN MinElute PCR Purification Kit (QIAGEN) and size-selected twice with Agencourt AMPure XP (1:1.5 and 1:0.5 sample to beads; Beckman Coulter, USA). Libraries were quantified by KAPA Library Quantification Kit for Illumina Sequencing Platforms (KAPA Biosystems, USA), and size distribution was determined by Bioanalyzer (Agilent Technologies, USA). The resulting ATAC-seq libraries were sequenced using single-end reads of 50 bp on the Illumina HiSeq 2500 (Illumina).
Kundajelab pipeline for ATAC-seq (https://github.com/kundajelab/atac_dnase_pipelines) was used for read processing, peak calling, and quality control 33 . Briefly, fastq files were grouped together and input separately into the pipeline. After mapping to hg38 reference genome, peaks were called by MACS2 48 for both individual samples and pooled replicates. A reference peak file was created by merging all pooled peaks from all four conditions and removing gaps smaller than 100 bp. After merging all detected ATAC-seq peaks in all cell types and conditions, a total of 254,578 open chromatin regions were detected. Finally, the raw reads in the reference peak regions were counted individually for each sample, using the multicov function of the bedtools software v2.27.0
(https://bedtools.readthedocs.io/en/latest/). For gene-based analysis, each peak was assigned to the closest gene.
Hierarchical clustering and motif analysis of CAGE genes and ATAC peaks
Hierarchical clustering analysis was performed using the average linkage algorithm with a Spearman correlation distance matrix. Motif enrichment analysis was performed using an R package chromVar using the default set of motifs with some modifications 40 . Z score for significance of motif enrichment was used as enrichment score.
Statistics
To evaluate the significance of differences in gene expression (RT-qPCR/CAGE), motility phenotype, and chromatin accessibility (ATAC-seq), a two-tailed Student's t-test was used to calculate p-values.
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